tm logo

Monitor this mark

View On USPTO

IMFINZI
Live/Registered
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED

on 02 Oct 2024

Last Applicant/ Owned by

AstraZeneca AB

Vastra Malarehamnen 9

Södertälje

SE

SE-151 85

Serial Number

79218364 filed on 24th Aug 2017

Registration Number

5488935 registered on 12th Jun 2018

in the Principal Register

Correspondent Address

Cara M. Kearney

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Wilmington, DE 19850-5437

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

IMFINZI

Pharmaceutical preparations and substances for use in oncology

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for use in oncology

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79218364

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 103483/WO-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

24.15.04 -

Arrowheads

26.01.03 -

Incomplete circles (more than semi-circles)

26.01.21 -

Circles that are totally or partially shaded

Legal History

Show more

Status DateAction Taken
02th Oct 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02th Oct 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
23rd Sep 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08th Jan 2024TEAS SECTION 71 & 15 RECEIVED
12th Jun 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12th Oct 2018FINAL DECISION TRANSACTION PROCESSED BY IB
21st Sep 2018FINAL DISPOSITION PROCESSED
21st Sep 2018FINAL DISPOSITION NOTICE SENT TO IB
12th Sep 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12th Jun 2018REGISTERED-PRINCIPAL REGISTER